Skip to main content

DefenCath Side Effects

Generic name: heparin / taurolidine catheter lock solution

Note: This document provides detailed information about DefenCath.

Applies to heparin/taurolidine catheter lock solution: intraluminal solution Side Effects associated with heparin / taurolidine catheter lock solution. Some dosage forms listed on this page may not apply specifically to the brand name DefenCath.

Applies to heparin/taurolidine catheter lock solution: intraluminal solution.

General adverse events

The most common adverse effects occurring in 2% of patients or greater included hemodialysis catheter malfunction, hemorrhage/bleeding, nausea, vomiting, dizziness, musculoskeletal chest pain, and thrombocytopenia.[Ref]

Gastrointestinal

Hematologic

Hemorrhage/bleeding includes hematoma/hemorrhage, intracranial hemorrhage, arteriovenous graft or fistula site hemorrhage, catheter site hematoma/hemorrhage, cerebral/cerebellar hemorrhage, eye/conjunctival hemorrhage, gastrointestinal hemorrhage, hematuria, hemobilia, hemoptysis, renal hematoma, and vaginal/uterine hemorrhage.

Hypersensitivity

Metabolic

Musculoskeletal

Nervous system

Other

References

1. (2024) "Product Information. Defencath (heparin-taurolidine catheter lock solution)." CorMedix

Does DefenCath interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

Further information

DefenCath side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.